Phillips Andrew John
SEC insider (Form 3/4/5 filer). CIK 0001921956. Director at OnKure Therapeutics, Inc. (OKUR) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in BOULDER, CO.
Companies Phillips Andrew John has filed insider reports for
- OnKure Therapeutics, Inc. (OKUR): Director
- MoonLake Immunotherapeutics (MLTX): Director
- Enliven Therapeutics, Inc. (ELVN): Director
Phillips Andrew John
CIK: 0001921956
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
22.4K shares- - Jun 17, 2026MLTX
MoonLake Immunotherapeutics
AwardDirectOption to Buy
22.2K shares- - Jun 4, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
7.7K shares- - Jun 5, 2025MLTX
MoonLake Immunotherapeutics
AwardDirectOption to Buy
6.7K shares- - May 28, 2025OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
7.7K shares- - Feb 6, 2025ELVN
Enliven Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20.5K shares- - Oct 4, 2024OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 |  OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 22,350 | - | - | Direct |
| Jun 17, 2026 |  MLTX MoonLake Immunotherapeutics | Award Option to Buy | 22,195 | - | - | Direct |
| Jun 4, 2026 | OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 7,650 | - | - | Direct |
| Jun 5, 2025 | MLTX MoonLake Immunotherapeutics | Award Option to Buy | 6,682 | - | - | Direct |
| May 28, 2025 | OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 7,650 | - | - | Direct |
| Feb 6, 2025 |  ELVN Enliven Therapeutics, Inc. | Award Stock Option (right to buy) | 20,491 | - | - | Direct |
| Oct 4, 2024 | OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 15,300 | - | - | Direct |
1-7 of 7 transactions